Figure 2.
Genomic and mutational landscape in plasmablastic lymphoma. (A) An oncoplot of genes mutated in at least 3 PBL samples after PBL MutSigCV analysis (P < .05) with allele frequencies added (left bar) and samples affected (right bar). Different types of mutations are color coded. In addition, covariates are shown below the plot for each sample. EBV-encoded RNA [EBER] EBV/HIV: neg, negative; pos, positive. MYC fluorescence in situ hybridization (FISH): ab, aberrated; NA, not available; wt, wild type. Progress: PD, progression disease; R, remission; SD, stable disease. (B) Location of SCNVs along the genome (red bars denote gains; blue bars denote losses; gene names refer to affected oncogenes and genes related to oncogenetic pathways). (C) Selected genes (oncogenes and oncogenetic pathway genes) affected by SCNVs.

Genomic and mutational landscape in plasmablastic lymphoma. (A) An oncoplot of genes mutated in at least 3 PBL samples after PBL MutSigCV analysis (P < .05) with allele frequencies added (left bar) and samples affected (right bar). Different types of mutations are color coded. In addition, covariates are shown below the plot for each sample. EBV-encoded RNA [EBER] EBV/HIV: neg, negative; pos, positive. MYC fluorescence in situ hybridization (FISH): ab, aberrated; NA, not available; wt, wild type. Progress: PD, progression disease; R, remission; SD, stable disease. (B) Location of SCNVs along the genome (red bars denote gains; blue bars denote losses; gene names refer to affected oncogenes and genes related to oncogenetic pathways). (C) Selected genes (oncogenes and oncogenetic pathway genes) affected by SCNVs.

Close Modal

or Create an Account

Close Modal
Close Modal